Blue Yellow IKEA 220mg mdma, ecstasymdma.com issued an ‘extreme high dose’ warning because this tablet contains more than 200mg of MDMA. This is a bi-layer tablet (one side is Yellow with Ikea, the reverse side is Blue).
Blue Yellow IKEA 220mg mdma, heritagechemicals.info issued an ‘extreme high dose’ warning because this tablet contains more than 220mg of MDMA. This is a bi-layer tablet (one side is Yellow with Ikea, the reverse side is Blue).
Purchase Blue Yellow IKEA 220mg mdma Online, party pills price in pakistan
Blue Yellow IKEA 220mg mdma, mollymdma.org issued an ‘extreme high dose’ warning because this tablet contains more than 220mg of MDMA. This is a bi-layer tablet (one side is Yellow with Ikea, the reverse side is Blue).
3,4-Methylenedioxymethamphetamine (MDMA),[note 1] commonly known as ecstasy (E) or molly, is a psychoactive drug primarily used for recreational purposes. The desired effects include altered sensations, increased energy, empathy, as well as pleasure. When taken by mouth, effects begin in 30 to 45 minutes and last 3 to 6 hours.
Adverse effects include addiction, memory problems, paranoia, difficulty sleeping, teeth grinding, blurred vision, sweating and a rapid heartbeat. Deaths have been reported due to increased body temperature and dehydration. Following use people often feel depressed and tired. MDMA acts primarily by increasing the activity of the neurotransmitters serotonin, dopamine and noradrenaline in parts of the brain. It belongs to the substituted amphetamine classes of drugs and has stimulant and hallucinogenic effects.
MDMA is illegal in most countries and, as of 2018, has no approved medical uses. Limited exceptions are sometimes made for research. Researchers are investigating whether MDMA may assist in treating severe, treatment-resistant posttraumatic stress disorder (PTSD) with phase 3 clinical trials to look at effectiveness and safety expected to begin in 2018. In 2017, the FDA granted MDMA a breakthrough therapy designation[note 2] for PTSD, meaning that if studies show promise, a review for potential medical use could occur more quickly.
MDMA was first developed in 1912 by Merck. It was used to enhance psychotherapy beginning in the 1970s and became popular as a street drug in the 1980s. MDMA is commonly associated with dance parties, raves, and electronic dance music. It may be mixed with other substances such as ephedrine, amphetamine, and methamphetamine. In 2016, about 21 million people between the ages of 15 and 64 used ecstasy (0.3% of the world population). This was broadly similar to the percentage of people who use cocaine or amphetamines, but lower than for cannabis or opioids. In the United States, as of 2017, about 7% of people have used MDMA at some point in their lives and 0.9% have used it in the last year.